• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    SciSparc Ltd. - Ordinary Shares (NQ:SPRC)

    8.745 -0.285 (-3.16%)
    Streaming Delayed Price Updated: 3:06 PM EDT, Apr 30, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 30,129
    Open 8.800
    Bid (Size) 8.560 (100)
    Ask (Size) 8.940 (100)
    Prev. Close 9.030
    Today's Range 8.000 - 8.800
    52wk Range 0.2518 - 9.030
    Shares Outstanding 145,148,593
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    These stocks are moving in today's session ↗
    Via Chartmill
    Unusual volume stocks are being observed in Tuesday's session. ↗
    Via Chartmill

    Performance

    YTD
    +524.6%
    +524.6%
    1 Month
    +143.1%
    +143.1%
    3 Month
    +946.7%
    +946.7%
    6 Month
    +157.2%
    +157.2%
    1 Year
    +3036.7%
    +3036.7%

    More News

    Read More
    Traders are paying attention to the gapping stocks in Tuesday's session. ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
    From SciSparc Ltd
    Via GlobeNewswire
    Which stocks are moving on Tuesday? ↗
    Via Chartmill
    Stay updated with the stocks that are on the move in today's pre-market session. ↗
    Via Chartmill
    News headline image
    SciSparc: Subsidiary NeuroThera Labs (75%) Signs Definitive Agreement to Acquire Majority Stake in CliniQuantum, Innovator in Quantum-based Clinical trails
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
    From Clearmind Medicine Inc.
    Via GlobeNewswire
    News headline image
    SciSparc Announces 1-for-9 Reverse Share Split
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: NeuroThera Labs Granted U.S. Patent for Cannabinoid Technology to Overcome Antimicrobial Resistance such as MRSA
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Successfully Completes Acquisition of IP Portfolio, Advances Toward Immediate Commercialization
    From SciSparc Ltd
    Via GlobeNewswire
    Which stocks are moving after the closing bell on Wednesday? ↗
    Via Chartmill
    These stocks are gapping in today's session ↗
    Via Chartmill
    These stocks that are showing activity before the opening bell on Tuesday. ↗
    Via Chartmill
    News headline image
    SciSparc Signs Definitive Agreement to Acquire a Treasury of Patents for the Endoscope Market- Entering Multi-Billion Dollar Opportunity
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Announces Receipt of Nasdaq Notification of Minimum Stockholders’ Equity Non-Compliance
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc: Neurothera Labs Granted Patent by Israeli Patent Office for its Proprietary Opioid-Based Patent Family to Enhance Pain Relief and Reduce Side Effects
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Via Chartmill
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    SciSparc: Neurothera Labs Signs Non-Binding Term Sheet to Acquire Majority Stake in a Quantum Algorithm Bio Data Analysis Company
    From SciSparc Ltd
    Via GlobeNewswire
    News headline image
    SciSparc Plans on Entering the Multi-Billion-Dollar GERD Device Market with Acquisition of an Approved IP Portfolio
    From SciSparc Ltd
    Via GlobeNewswire

    Frequently Asked Questions

    Is SciSparc Ltd. - Ordinary Shares publicly traded?
    Yes, SciSparc Ltd. - Ordinary Shares is publicly traded.
    What exchange does SciSparc Ltd. - Ordinary Shares trade on?
    SciSparc Ltd. - Ordinary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for SciSparc Ltd. - Ordinary Shares?
    The ticker symbol for SciSparc Ltd. - Ordinary Shares is SPRC on the Nasdaq Stock Market
    What is the current price of SciSparc Ltd. - Ordinary Shares?
    The current price of SciSparc Ltd. - Ordinary Shares is 8.745
    When was SciSparc Ltd. - Ordinary Shares last traded?
    The last trade of SciSparc Ltd. - Ordinary Shares was at 04/30/26 03:06 PM ET
    What is the market capitalization of SciSparc Ltd. - Ordinary Shares?
    The market capitalization of SciSparc Ltd. - Ordinary Shares is 1.27B
    How many shares of SciSparc Ltd. - Ordinary Shares are outstanding?
    SciSparc Ltd. - Ordinary Shares has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.